Second, the gene MUC16/CA125, a widely used biomarker of ovarian cancer in clinical practice59, 60, was shown to be highly upregulated in small putative cancer stem cells from borderline ovarian cancer in comparison with small stem cells from “healthy” ovaries, hESCs, and human fibroblasts. This evidence concerns the gene MUC16 and ovarian cancer.